Ordinant holds a WDA (H) and can provide pharmaceutical wholesale services to clients.
Ordinant can provide a sourcing and importation service for so-called “named patient” unlicensed medicines from outside the EEA.
Through our partners, Ordinant is able to provide a range of repacking solutions for clients including over-labeling, re-boxing, application of serialization codes, and tamper-evident seals.
Ordinant has an in-house regulatory service that can assist in applications for licenses through the MHRA.
The requirements for GDP and the associated Quality Management System (QMS) are becoming increasingly complex and onerous.
The team at Ordinant has a wealth of experience in the UK market in both primary and secondary care and can provide consultancy advice.
Ordinant Medical Solutions was founded in early 2012 to provide pharmaceutical repacking services through successfully gaining an MIA and WDA (H) licences with the MHRA. It shared facilities with two other pharmaceutical wholesalers in Accrington, Lancashire. In 2014, it extended the services it could provide by gaining a manufacturing specials licence for the importation of territory unlicensed medicines. In 2017, Ordinant transferred its operation to new facilities at Blackburn Technology Management Centre, where it has additional space to extend its pharmaceutical wholesale services for its clients.